| abstract |
FIELD: medicine; pharmaceuticals.SUBSTANCE: invention relates to a compound of formula (I), in which radicals and groups have values given in the claim, or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing said compounds.EFFECT: said compounds have activity to inhibit positive effect of factor Xa and can be used for preparing a drug for prevention and/or treatment of diseases, which inhibits positive action of factor Xa in case of low risk of bleeding.18 cl, 6 tbl, 35 ex |